Abstract #1905
Theranostic prospects of gadolinium-based mesoporous silica nanoparticle probes for functional MRI
Veronika Mamaeva 1,2 , Tina Pavlin 3,4 , Didem Sen Karaman 5 , Diti Desai 5 , Melanie Ostermann 1 , Jessica Rosenholm 5 , and Emmet McCormack 1,2
1
Department of Clinical Science, Hematology
Section, University of Bergen, Bergen, Norway,
2
Department
of Internal Medicine, Hematology Section, Haukeland
University Hospital, Bergen, Norway,
3
Department
of Biomedicine, Molecular Imaging Center, University of
Bergen, Bergen, Norway,
4
Department
of Radiology, Haukeland University Hospital, Bergen,
Norway,
5
Laboratory
of Physical Chemistry, bo Akademi University, Turku,
Finland
A novel mesoporous silica nanoparticle MRI probe with
theranostic prospects for targeted drug delivery was
developed and applied to imaging of subcutaneous tumors
in mice. Animals were injected either with Gd-doped
MSNPs, pristine MSNPs, or Dotarem, and T1-weighted RARE
images were collected pre- and at various time points
post contrast injection. We observed a slight, but
significant, increase of SI on T1-weighted images of
GadoNPs-treated tumors at 24 hours. Conclusion: Gddoped
MSNPs are retained for at least 96 hours in tumor tissue
and can be visualized by MRI, suggesting feasibility of
using this NP platform for future theranostic
applications.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
